6 reports

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Cystic Fibrosis
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Gilead' s product portfolio and pipeline of investigational drugs encompasses treatments for HIV/ AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions.

  • Cystic Fibrosis
  • AbbVie Inc.
  • Allergan plc
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated

Engages in the development of drugs for HIV/ AIDS, liver diseases, hematology, oncology, cardiovascular, inflammation, respiratory, and other therapies.

  • Cystic Fibrosis
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Royalty Pharma Acquires Royalties on Cystic Fibrosis Treatments from Cystic Fibrosis Foundation Therapeutics for USD3.3 Billion

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Cystic Fibrosis
  • United States
  • Company Financials
  • M&A
  • RP Management LLC
  • ROYALTY PHARMA ACQUIRES ROYALTIES ON CYSTIC FIBROSIS TREATMENTS FROM CYSTIC FIBROSIS FOUNDATION THERAPEUTICS FOR USD3.3 BILLION

It offers its approved products in the therapeutic areas of rheumatoid arthritis (RA), Crohn' s disease, diabetes, chronic kidney disease, HIV/ AIDS and others.

  • Cystic Fibrosis
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

The prominent features of this report are - ##.

  • Clinical Trial
  • Cystic Fibrosis
  • Therapy
  • World
  • Product Initiative